1. Home
  2. WULF vs AMPH Comparison

WULF vs AMPH Comparison

Compare WULF & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TeraWulf Inc.

WULF

TeraWulf Inc.

HOLD

Current Price

$12.54

Market Cap

6.1B

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$27.32

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WULF
AMPH
Founded
1952
1996
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
1.2B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
WULF
AMPH
Price
$12.54
$27.32
Analyst Decision
Strong Buy
Buy
Analyst Count
12
6
Target Price
$16.71
$31.00
AVG Volume (30 Days)
34.9M
396.5K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$167,604,000.00
$723,305,000.00
Revenue This Year
$33.36
$1.35
Revenue Next Year
$124.75
$5.10
P/E Ratio
N/A
$11.72
Revenue Growth
30.58
N/A
52 Week Low
$2.06
$20.39
52 Week High
$17.05
$40.74

Technical Indicators

Market Signals
Indicator
WULF
AMPH
Relative Strength Index (RSI) 44.60 57.96
Support Level $11.32 $25.16
Resistance Level $13.64 $26.50
Average True Range (ATR) 1.27 0.85
MACD -0.32 0.03
Stochastic Oscillator 22.47 80.63

Price Performance

Historical Comparison
WULF
AMPH

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: